Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04232683 · ClinicalTrials.gov registry record · Early Phase 1
Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders
A Early Phase 1 study of Urinary Retention, sponsored by The Cleveland Clinic.
- Active
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04232683: Active Early Phase 1 study of Urinary Retention, sponsored by The Cleveland Clinic.
NCT04232683 is a Early Phase 1 study of Urinary Retention that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 100 participants, below the 131-participant average among 11 other Urinary Retention trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04232683, a Early Phase 1 study of Urinary Retention, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Our hypothesis is that patients receiving preoperative Tamsulosin will have decrease rates of postoperative urinary retention (POUR) after surgery in females for pelvic floor disorders.
Primary Outcome
Assess the effect of Tamsulosin in preventing POUR, defined by failure of initial voiding trial postoperatively.
Conditions Studied
Interventions
- DRUG Placebo oral tablet
- DRUG Tamsulosin 0.4Mg Capsule
Study Locations (1)
Florida
- Cleveland Clinic Florida - Weston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-12-18 |
| Est. Completion | 2025-12 |
| Phase | Early Phase 1 |
What the registry record for NCT04232683 still lists
NCT04232683 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 131-participant average among 11 other Urinary Retention trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Urinary Retention appearing as the primary indexed condition, and to 2 interventions - of which Placebo oral tablet is the first listed.
NCT04232683 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04232683 about?
NCT04232683 is a clinical study titled "Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders". Our hypothesis is that patients receiving preoperative Tamsulosin will have decrease rates of postoperative urinary retention (POUR) after surgery in females for pelvic floor disorders.
What is the current status of trial NCT04232683?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2019-12-18. Estimated completion is 2025-12.
What conditions does trial NCT04232683 study?
This clinical trial studies the following conditions: Urinary Retention.
What interventions are being tested in trial NCT04232683?
The interventions under investigation include: Placebo oral tablet (DRUG), Tamsulosin 0.4Mg Capsule (DRUG).
Who is sponsoring clinical trial NCT04232683?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04232683 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Retention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04232683's enrollment target sits among peer trials
100 5th of 11 higher than 7 of 11 other Urinary Retention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Retention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
RECRUITING · Early Phase 1
-
Comparison of Urinary Flow Study
RECRUITING · NA
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
-
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
-
Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI